Carl Icahn and Illumina Proxy Fight Consequence: CEO Survives, Chairman Is Out
Activist investor Carl Icahn needs a gain at Illumina just after a string of issues elsewhere. ...
Read moreActivist investor Carl Icahn needs a gain at Illumina just after a string of issues elsewhere. ...
Read moreTextual content dimension Amgen had aid it envisioned its acquisition of Horizon Therapeutics to be finished ...
Read moreHealth care Stocks Are on Sale. Pfizer and Stryker Have Sturdy Progress Prospective buyers.
Read moreText dimension Merck agreed to buy Prometheus Biosciences for about $10.8 billion. Michael Vi/Dreamstime Inventory futures ...
Read moreMerck to Purchase Prometheus Biosciences
Read moreText sizing Moderna gave an update on its portfolio of vaccines. Getty Illustrations or photos Moderna ...
Read moreText sizing Costco said identical-retailer income declined 1.1% in March. Joe Raedle/Getty Illustrations or photos Inventory ...
Read moreText size GameStop reported a shock revenue in its fiscal fourth quarter. Justin Sullivan/Getty Visuals Inventory ...
Read moreText measurement Li Vehicle said it expects initially-quarter deliveries to surge. Qilai Shen/Bloomberg Inventory futures rose ...
Read moreEnphase sees strong demand for its made-in-America gear for solar panels. Courtesy Enphase Text size A ...
Read more